ALX 404C

Drug Profile

ALX 404C

Alternative Names: 4C; ALX40; ALX40-4

Latest Information Update: 06 May 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NPS Allelix
  • Class Antivirals
  • Mechanism of Action Human immunodeficiency virus tat gene product inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 06 May 1998 A clinical study has been added to the drug interactions section
  • 05 Feb 1997 Discontinued-II for HIV infections treatment in Canada (PO)
  • 19 Sep 1995 A dose-escalation study has been added to the pharmacokinetics and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top